NCT03771547

Brief Summary

Today 11 percent of China's population is over the age of 65, and according to United Nations, it will take China just 20 years for the proportion of the elderly population to double to 25%. As life expectancy has increased, application of Endoscopic Retrograde Cholangiopancreatography (ERCP) in super-aged (≥80 years of age) is no longer limited with increasing prevalence of choledocholithiasis, and malignancy in advancing age. This increasing may come with more difficulty in cannulation or more complications in senior patients. Regarding difficult cannulation, little is known about grading difficulty in the elderly and its relation with adverse events. Therefore, it is time to evaluate the risk factors of adverse events in super-aged patients with difficult bile duct cannulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
614

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 11, 2018

Completed
Last Updated

December 11, 2018

Status Verified

February 1, 2018

Enrollment Period

1.6 years

First QC Date

October 7, 2018

Last Update Submit

December 8, 2018

Conditions

Keywords

ERCPElderlyDifficult cannulation

Outcome Measures

Primary Outcomes (1)

  • Adverse events in difficult cannulation patients

    Multi-variate regression will be used to check the risk factors of adverse events

    30 days

Study Arms (2)

More 80

The first group included ERCP patients aged 80 and above.

Diagnostic Test: ERCP

Less 80

The second group included those ERCP patients younger than 80.

Diagnostic Test: ERCP

Interventions

ERCPDIAGNOSTIC_TEST
Less 80More 80

Eligibility Criteria

Age16 Years - 94 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

No specific restrictions on selecting the patients.

You may qualify if:

  • Patients who underwent ERCP between July 2016 and January 2018.

You may not qualify if:

  • We excluded the patients who underwent ERCP for the objectives of follow up, stent removing or taking a biopsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210011, China

Location

Related Publications (1)

  • Tabak F, Ji GZ, Miao L. Impact of periampullary diverticulum on biliary cannulation and ERCP outcomes: a single-center experience. Surg Endosc. 2021 Nov;35(11):5953-5961. doi: 10.1007/s00464-020-08080-8. Epub 2020 Oct 7.

MeSH Terms

Conditions

Cholangitis

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Lin Miao, PhD

    Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2018

First Posted

December 11, 2018

Study Start

July 1, 2016

Primary Completion

January 30, 2018

Study Completion

March 1, 2018

Last Updated

December 11, 2018

Record last verified: 2018-02

Locations